Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIVACAST: Rivaroxaban vs LMWH in Lower Limb Trauma
NCT06195540Phase 3Recruiting
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Jul 2024
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in venous thromboembolism (VTE), sponsored by Centre Hospitalier Universitaire d'Angers. Started Jul 2024; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT06195540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06195540.